Standout Papers
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer (2008)
- Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery (2005)
- A Functional Genetic Approach Identifies the PI3K Pathway as a Major Determinant of Trastuzumab Resistance in Breast Cancer (2007)
- The biology of ovarian cancer: new opportunities for translation (2009)
- Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy (2007)
- The energy sensing LKB1–AMPK pathway regulates p27kip1 phosphorylation mediating the decision to enter autophagy or apoptosis (2007)
- Ovarian cancer (2009)
- Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer (2012)
Immediate Impact
8 by Nobel laureates 15 from Science/Nature 122 standout
Citing Papers
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer
2022 Standout
A pan-cancer compendium of chromosomal instability
2022 StandoutNature
Works of Bryan T. Hennessy being referenced
Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer
2012 Standout
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
2008 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Bryan T. Hennessy | 8714 | 9505 | 6232 | 259 | 19.1k | |
| Britta Weigelt | 7897 | 7666 | 8261 | 304 | 18.6k | |
| Ann D. Thor | 9580 | 8212 | 5736 | 209 | 18.1k | |
| Michael J. Duffy | 7872 | 8834 | 6877 | 260 | 18.6k | |
| Lars A. Akslen | 13751 | 13581 | 11352 | 307 | 28.4k | |
| Stan B. Kaye | 9366 | 8573 | 3569 | 214 | 18.9k | |
| Åke Borg | 6824 | 10142 | 6729 | 275 | 18.3k | |
| John M.S. Bartlett | 10284 | 6062 | 6777 | 306 | 18.4k | |
| Timothy A. Yap | 8412 | 8786 | 3216 | 340 | 15.7k | |
| Thomas J. Giordano | 4463 | 9044 | 5349 | 239 | 18.8k | |
| Frédérique Penault‐Llorca | 10512 | 5243 | 6950 | 331 | 18.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...